A novel dual-target steroid sulfatase inhibitor and antiestrogen : SR 16157, a promising agent for the therapy of breast cancer
RASMUSSEN, Louise M, ZAVERI, Nurulain T, STENVANG, Jan, PETERS, Richard H, LYKKESFELDT, Anne E
Published in Breast cancer research and treatment (01.12.2007)
Published in Breast cancer research and treatment (01.12.2007)
Get full text
Journal Article
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
Frogne, Thomas, Benjaminsen, Rikke V, Sonne-Hansen, Katrine, Sorensen, Boe S, Nexo, Ebba, Laenkholm, Anne-Vibeke, Rasmussen, Louise M, Riese, David J. II, de Cremoux, Patricia, Stenvang, Jan, Lykkesfeldt, Anne E
Published in Breast cancer research and treatment (01.03.2009)
Published in Breast cancer research and treatment (01.03.2009)
Get full text
Journal Article